In the serum and CSF of ALS patients, IL-6 and IL-18 are increased while IL-37 is absent, suggesting that IL-6 and IL-18 are involved in the pathological progression of ALS and can be used as inflammatory markers for ALS [166]. Here, IL18 is linked to amyotrophic lateral sclerosis.